4//SEC Filing
Murray Dallan 4
Accession 0000950170-25-020192
CIK 0000873303other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 8:00 PM ET
Size
5.8 KB
Accession
0000950170-25-020192
Insider Transaction Report
Form 4
Murray Dallan
Chief Customer Officer
Transactions
- Award
Performance Restricted Stock Units
2025-02-11+3,500→ 17,500 total→ Common Stock (3,500 underlying)
Footnotes (1)
- [F1]Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date.
Documents
Issuer
Sarepta Therapeutics, Inc.
CIK 0000873303
Entity typeother
Related Parties
1- filerCIK 0002022303
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 8:00 PM ET
- Size
- 5.8 KB